NeuroPace Corp (NPCE) - Net Sales Margin

NeuroPace Inc (NPCE) - corporate logo

The stabilization of microchip supply chains ensures the uninterrupted production of NeuroPace, Inc. (NPCE) systems. A monopoly position in neuromodulation and inelastic demand allow the company to flexibly manage its pricing power. High surgeon confidence confirms its status as an innovator in epilepsy treatment. This net profitability chart clearly demonstrates cost management efficiency, with the latest data point standing at -20.00, which helps assess the overall financial stability of the business.

NeuroPace Medical (NPCE) - Return on Sales by Net Profit from 07/04/2022 to 11/19/2026

Financial and market metric breakdowns for NeuroPace, Inc. (NPCE)

- share price and expert price forecast:
Summary company analytics:NeuroPace Medical - NPCE
Manufactured product of NeuroPace Medical

To assess the credit quality of NeuroPace, Inc. (NPCE), the analyst examines the net profit margin, which utilizes the commercial profitability level to distinguish overvalued assets from a truly growing business. This indicator reflects the monetization efficiency of implantable neurostimulators and ancillary services, demonstrating what percentage of sales from unique devices is transformed into the company's bottom line after all expenses.

Analysis of competing companies

DXCM: Net Sales Margin|PEN - Company Sales Margin|NOVT (Novanta Photonics) - Net Sales Margin|Return on Sales by Net Profit Haemonetics Corp. (HAE)|Net Sales Margin INSP|Return on Sales by Net Profit PROCEPT BioRobotics PRCT|Net Sales Margin CNMD (conmed.com)|Net Sales Margin Pulse Biosciences Inc PLSE|INMD - Net Margin|Net Profit Rate PMI (Picard Medical Inc.)|SRDX (Surmodics, Inc.) - Return on Sales by Net Profit|Eversense - Net Profit Rate|TCMD (Tactile Systems Technology, Inc.) - Net Sales Margin|Net Margin SANUWAVE Health SNWV|Net Sales Margin OM|Electromed Inc (ELMD) - Net Profitability Margin|LENSAR Inc - Return on Sales by Net Profit|Net Sales Margin AVITA Medical, Inc. RCEL|Profound Medical Corp - Net Sales Margin|Company Sales Margin Baird Medical BDMD|EDAP TMS (EDAP) - Net Margin|Net Profit Margin APYX (Bovie Medical)|Net Margin icecure-medical.com|Return on Sales by Net Profit Pulmonx Corporation (LUNG)|Net Sales Margin TELA|CTSO - Net Margin|Net Margin Sensus Healthcare, Inc. SRTS|ZYXI: Net Return on Sales|ECOR: Return on Sales by Net Profit|Vicarious Surgical Inc - Company Net Profitability|IINN: Net Sales Margin|Net Margin SeaStar Medical (ICU)|Net Margin iridex.com|Net Return on Sales INBS (Intelligent Bio Solutions Inc.)|Return on Sales by Net Profit XAIR (Beyond Air, Inc.)|PFSA - Net Margin|Net Sales Margin SSKN (STRATA Skin Sciences Inc.)|GCTK - Return on Sales by Net Profit|NAOV: Return on Sales by Net Profit|Company Sales Margin Venus Concept Inc. VERO|Nuwellis, Inc. (NUWE) - Net Margin|Net Margin aethlonmedical.com (AEMD)|Net Margin Asensus Surgical|AVGR: Net Profit Rate|Return on Sales by Net Profit BSGM (BioSig Technologies, Inc.)|Company Sales Margin Cutera Inc|Know Labs, Inc. - Return on Sales by Net Profit|NARI: Net Return on Sales|NVRO - Net Margin|Company Sales Margin reshapelifesciences.com RSLS|Silk Road Medical Inc (SILK) - Net Margin